Entyvio 300 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FDJN3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,018
Award facts
- Contract value 100% obligated
- $31,018.42 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $31,018.42 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. The contract is firm fixed-price with an ultimate completion date of January 21, 2026, and carries no set-aside designation, indicating the vendor competed for this award in open procurement. DMS Pharmaceutical Group was selected as the prime contractor with no identified subcontractors, demonstrating the company's direct capability to fulfill this pharmaceutical supply requirement for Department of Defense military healthcare operations.
This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy established to provide comprehensive pharmaceutical and medical supply support to military healthcare facilities worldwide. The underlying IDC, designated as contract SPE2DR and awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. As one of multiple regional prime vendor contractors under this framework, DMS Pharmaceutical Group's established performance across numerous delivery orders positions the company as a critical supplier within the federal military pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DR26FDJN3?
SPE2DR26FDJN3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FDJN3 worth?
The government has obligated $31,018 on SPE2DR26FDJN3.
Is contract SPE2DR26FDJN3 an order under another contract?
Yes. SPE2DR26FDJN3 is a delivery order under SPE2DR25D9144, an indefinite delivery contract.
Was contract SPE2DR26FDJN3 competed?
The extent of competition for SPE2DR26FDJN3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award